SCHEMBL2659537

SCHEMBL2659537

Cc1ccc[nH]c1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27700371 0.69
SCHEMBL10987236 0.68
SCHEMBL146698 0.68
SCHEMBL1661731 0.68
SCHEMBL272130 0.68
SCHEMBL30519269 0.68
SCHEMBL8091109 0.68
SCHEMBL3223865 0.67
Iodide SCHEMBL11482211 0.67
SCHEMBL3782742 0.67 HDAC8 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0836602-B1 FUNGICIDAL PYRIMIDINONES DU PONT (US) 2002-01-30 EP claimed
US-10682330-B2 Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside ENSUIKO SUGAR REFINING CO., LTD. (JP) 2020-06-16 US disclosed
EP-2829273-B1 METHOD FOR PRODUCING LIPOSOME ENCAPSULATING PACLITAXEL MONOGLYCOSIDE AND/OR DOCETAXEL MONOGLYCOSIDE ENSUIKO SUGAR REFINING (JP) 2018-08-29 EP disclosed
EP-3078662-A1 PYRIDIN-2-YL-AMINO-1,2,4-THIADIAZOLE DERIVATIVES AS GLUCOKINASE ACTIVATORS FOR THE TREATMENT OF DIABETES MELLITUS Array Biopharma, Inc. (US) 2016-10-12 EP disclosed
US-20160256566-A2 METHOD FOR PRODUCING LIPOSOME ENCAPSULATING PACLITAXEL MONOGLYCOSIDE AND/OR DOCETAXEL MONOGLYCOSIDE ENSUIKO SUGAR REFINING CO., LTD. (JP) 2016-09-08 US disclosed
EP-2727910-B1 Pyridin-2-yl-thiourea and Pyridin-2-yl-amine derivatives as intermediates for the preparation of Pyridin-2yl-amino-1,2,4-thiadiazole glucokinase activators ARRAY BIOPHARMA INC (US) 2016-03-16 EP disclosed
US-9079890-B2 Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives ARRAY BIOPHARMA INC. (US) 2015-07-14 US disclosed
US-20150057448-A1 INTERMEDIATES FOR THE PREPARATION OF PYRIDIN-2-YL-AMINO-1,2,4-THIADIAZOLE DERIVATIVES ARRAY BIOPHARMA, INC. 2015-02-26 US disclosed
US-20150056270-A1 METHOD FOR PRODUCING LIPOSOME ENCAPSULATING PACLITAXEL MONOGLYCOSIDE AND/OR DOCETAXEL MONOGLYCOSIDE HAMADA HIROKI (JP) 2015-02-26 US disclosed
EP-2829273-A1 METHOD FOR PRODUCING LIPOSOME ENCAPSULATING PACLITAXEL MONOGLYCOSIDE AND/OR DOCETAXEL MONOGLYCOSIDE Ensuiko Sugar Refining Co.Ltd. (JP) 2015-01-28 EP disclosed
US-20100204240-A1 Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus ARRAY BIOPHARMA INC. (US) 2010-08-12 US disclosed
EP-2209778-A1 PYRIDIN-2 -YL-AMINO-I, 2, 4 -THIADIAZOLE DERIVATIVES AS GLUCOKINASE ACTIVATORS FOR THE TREATMENT OF DIABETES MELLITUS Array Biopharma, Inc. (US) 2010-07-28 EP disclosed
US-20100113759-A1 PROPARGYL SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS Life Technologies Corporation (US) 2010-05-06 US disclosed
US-20100113759-A1 PROPARGYL SUBSTITUTED NUCLEOSIDE COMPOUNDS AND METHODS Life Technologies Corporation (US) 2010-05-06 US disclosed
WO-2009058911-A2 PREPARATION AND ISOLATION OF 5' CAPPED MRNA APPLIED BIOSYSTEMS INC. (US) 2009-05-07 WO disclosed
WO-2009042435-A1 PYRIDIN-2 -YL-AMINO-I, 2, 4 -THIADIAZOLE DERIVATIVES AS GLUCOKINASE ACTIVATORS FOR THE TREATMENT OF DIABETES MELLITUS ARRAY BIOPHARMA INC. (US) 2009-04-02 WO disclosed
US-5093505-A Pyranone and pyran-thione derivatives WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1992-03-03 US disclosed
EP-0377031-A1 5-DEAZA-5,7-DISUBSTITUTED-AMINOPTERIN ANALOGUES Sloan-Kettering Institute For Cancer Research (US) 1990-07-11 EP disclosed
WO-1990000172-A1 5-DEAZA-5,7-DISUBSTITUTED-AMINOPTERIN ANALOGUES SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1990-01-11 WO disclosed
EP-0069872-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-01-19 EP disclosed